Prognostic Value of the Lactate-to-Albumin and C-Reactive Protein-to-Albumin Ratios in COVID-19–Associated ARDS
Journal of Clinical Medicine · 07.07.2026 · 15 (13) · 5294
DOI: 10.3390/jcm15135294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.07.2026. Verfasst von Sultan Almuntashiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ha'il, Scientific Research Deanship at University of Ha’il- Saudi Arabia.
Abstract (Originalsprache)
Background
Coronavirus disease 2019 (COVID-19) is frequently complicated by acute respiratory distress syndrome (ARDS), which is associated with high mortality. The lactate-to-albumin ratio (LAR) and C-reactive protein-to-albumin ratio (CAR) have been proposed as prognostic markers in critical illness, but their comparative performance in COVID-19–associated ARDS is not well established.
Methods
We conducted a retrospective cohort study using the MIMIC-IV database, which contains data from Beth Israel Deaconess Medical Center, United States, including COVID-19 ICU admissions from 2020 to 2022. Adult COVID-19 patients with available PaO2/FiO2, lactate, albumin, and C-reactive protein measurements within the first 48 h of ICU admission were included. Receiver operating characteristic analysis, Kaplan–Meier survival analysis, and Cox proportional hazards regression were performed.
Results
Of the 3620 patients screened, 66 met the inclusion criteria; 36 survived and 30 died. Non-survivors had significantly higher LAR and CAR values at ICU admission. In ROC analyses, LAR demonstrated moderate discrimination for 30-day mortality (AUC 0.706) and showed higher discriminatory performance than CAR in most subgroup analyses. Among ARDS patients, LAR showed moderate predictive ability (AUC 0.693), compared with CAR (AUC 0.655). In severe ARDS, both markers demonstrated improved discrimination (0.722 AUC for LAR and 0.797 for CAR). High LAR was associated with significantly higher 30-day mortality in all ARDS patients (60.5% vs. 24.0%; p = 0.0056) and severe ARDS patients (72.0% vs. 20.0%; p = 0.0022). Elevated CAR was also associated with increased mortality, particularly in severe ARDS (73.1% vs. 14.3%; p < 0.001). In multivariable Cox regression, LAR remained independently associated with 30-day mortality.
Conclusions
LAR demonstrated independent prognostic value for 30-day mortality in critically ill COVID-19 patients with ARDS. CAR showed variable performance. These readily available biomarkers, particularly LAR, may aid early risk stratification although larger studies are needed to confirm these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Department of Health Informatics, College of Public Health and Health Informatics, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Medical and Diagnosis Research Center, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Baha University, Al-Baha 65779, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia.
ORCID-Profile: Sultan Almuntashiri, Bader M Alshoumr, Saleh Alghamdi, Sirajudheen Anwar
Förderung
- University of Ha'il
- Scientific Research Deanship at University of Ha’il- Saudi Arabia
Zitieren
APA
Almuntashiri, S., Alsubhi, Y. A. M., Alhelali, Z. K. B., Alanazi, A. F. M., Alamri, M. M. B., Alshoumr, B. M., Alghamdi, S., Almermesh, M. H. S., Hussain, T., & Anwar, S. (2026). Prognostic Value of the Lactate-to-Albumin and C-Reactive Protein-to-Albumin Ratios in COVID-19–Associated ARDS. Journal of Clinical Medicine, 15(13), 5294. https://doi.org/10.3390/jcm15135294
Vancouver
Almuntashiri S, Alsubhi YAM, Alhelali ZKB, Alanazi AFM, Alamri MMB, Alshoumr BM, et al. Prognostic Value of the Lactate-to-Albumin and C-Reactive Protein-to-Albumin Ratios in COVID-19–Associated ARDS. Journal of Clinical Medicine. 2026;15(13):5294. doi:10.3390/jcm15135294
BibTeX
@article{Almuntashiri2026,
author = {Almuntashiri, Sultan and Alsubhi, Yazeed Adel M and Alhelali, Ziyad Khalid B and Alanazi, Abdulrahman Fraih M and Alamri, Meshari Mohammed B and Alshoumr, Bader M and Alghamdi, Saleh and Almermesh, Mohammad Hajaj Said and Hussain, Talib and Anwar, Sirajudheen},
title = {Prognostic Value of the Lactate-to-Albumin and C-Reactive Protein-to-Albumin Ratios in COVID-19–Associated ARDS},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {5294},
doi = {10.3390/jcm15135294}
}
EUVIMED